Results of a large French clinical trial evaluating Synolis VA
in knee osteoarthritis presented at EULAR 2020

LEARN MORE

Previous

Next

Home

OUR ORIGIN

Founded in 2013, Aptissen is a Swiss company leading-edge musculoskeletal expert that provides life-changing orthobiologic solutions or articulation disorders.
The Aptissen founders developed a unique hyaluronic acid injectable: Synolis VA to reduce the pain and discomfort caused by osteoarthrosis.
In 2019, Aptissen added to its portfolio Cartylis, a daily drinkable food supplement that promotes collagen synthesis to reboost the joints.

The company’s products are distributed through a worldwide distributors network among more than 50 countries, including Switzerland, France, Italy, Poland, Canada, Mexico, Brazil, UAE, Singapore Malaysia etc.…

OUR VISION

At Aptissen, we are committed to proven products to the pursuit of a pain-free world.

ORTHOPAEDICS

Aptissen launched Synolis VA, an intra-articular injection product for osteoarthritis, the first Visco-Antalgic on the market, with a unique combination of Hyaluronic Acid and high concentration of Sorbitol.
Synolis VA’s viscoelastic properties (patented formulation) are similar to the young and healthy synovial fluid, resulting in rapid mobility recovery, fast and long-lasting pain relief associated with excellent safety.

APTISSEN TEAM

The Aptissen team owns the knowledge and experience of both products and markets.

Contact us icon orange

NEED AN INFORMATION?

If you need an information, you can send us an email on our contact page.

Privacy Preference Center

    Necessary

    Advertising

    Analytics

    Other